Sagebrush Health Services, a nonprofit organization serving over 10,000 Nevada patients, has filed a lawsuit against Amgen Inc. (NASDAQ: AMGN), alleging that Amgen acted unlawfully by unilaterally ...

HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district ...

The US Department of Health and Human Services is negotiating with hospital groups about reconsidering a new drug rebate pilot that was scheduled to take effect Jan. 1, according to filings in a ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...

The Trump administration has signaled plans to drop its appeal of a court order that blocked a pilot from changing payment ...

The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the ...

A federal judge granted a temporary restraining order to block a pilot program aimed at keeping better tabs on the ...

A federal judge has granted a temporary restraining order that will stop HHS' much-contested 340B rebate model from launching as planned on 1st January. Judge Lance Walker sided with the American ...

The drug giant says an Eighth Circuit ruling last year in a case from Minnesota should block a similar law in Missouri.

Judges in the First US Circuit Court of Appeals in Boston have rejected an effort to overturn last month's injunction on the ...

When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...